Clinuvel Pharmaceuticals | CUV - Cash And Equivalent

Stock Price
9.13
Daily Change
0.15 1.67%
Monthly
-6.65%
Yearly
-19.13%
Q2 Forecast
8.87

Clinuvel Pharmaceuticals reported AUD35.2M in Cash and Equivalent for its fiscal semester ending in June of 2024.





Cash And Equivalent Change Date
Avita Medical AUD 10.24M 1.98M Dec/2025
Medical Developments International AUD 17.84M 219K Jun/2025
Mesoblast USD 129.57M 31.58M Dec/2025
Neuren Pharmaceuticals AUD 5.91M 2.76M Jun/2025
Pacific Edge NZD 29.26M 8.79M Jun/2024
Paradigm Biopharmaceuticals AUD 16.82M 1M Jun/2025
PYC Therapeutics AUD 153.05M 103.8M Jun/2025
Telix Pharmaceuticals AUD 207.16M 503.19M Jun/2025